Opaleye Management »

Ginkgo Bioworks Holdings Inc Cl A shares owned by Opaleye Management

Quarter-by-quarter ownership of Ginkgo Bioworks Holdings Inc Cl A shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Ginkgo Bioworks Holdings Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Ginkgo Bioworks Holdings Inc Cl A held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ginkgo Bioworks Holdings Inc Cl A by Opaleye Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.7M 820k 8.15

More positions owned by Opaleye Management

Harrow Health (HROW)
Tg Therapeutics (TGTX)
Ocular Therapeutix (OCUL)
Arvinas Ord (ARVN)
Codexis (CDXS)
Rhythm Pharmaceuticals (RYTM)
Keros Therapeutics (KROS)
Immunome (IMNM)
Liquidia Corporation Com New (LQDA)
Eton Pharmaceuticals (ETON)
Edgewise Therapeutics (EWTX)
Cargo Therapeutics (CRGX)
Applied Therapeutics (APLT)
Vaxcyte (PCVX)
Nurix Therapeutics (NRIX)

View all positions for Opaleye Management

Top funds holding Ginkgo Bioworks Holdings Inc Cl A

Viking Global Investors
Baillie Gifford & Co
Anchorage Capital Group
BlackRock
D. E. Shaw & Co
Susquehanna International
Opaleye Management
Erste Asset Management GmbH
Glenview Captal Management
Bank of America Corporation
Geode Capital Management
Monaco Asset Management SAM
Exchange Traded Concepts
Ensign Peak Advisors
Cubist Systematic Strategies

View all funds holding Ginkgo Bioworks Holdings Inc Cl A